Search results
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional...
Morningstar· 1 day agoXTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate< ...
King Charles is receiving treatment for cancer — doctors explain what happens next
The Today Show via AOL· 6 days ago“If you think about the prostate like a donut, and we urinate through the hole in the donut,”...
Urine test may determine prostate cancers' level of aggression
UPI· 6 days agoResearchers say they've developed a urine test that could answer whether prostate cancer is...
Brachytherapy for Prostate Cancer Linked to Higher Risk of Second Pelvic Malignancy
MedPage Today· 2 days agoPelvic second malignancy occurred twice as often after brachytherapy for prostate cancer as compared...
How Long Should Active Surveillance Last?
Medscape· 6 days agoMen with low-risk prostate cancer who go on active surveillance rather than treatment are best followed-up for more than 15 years — and ...
20 Countries with the Highest Cancer Survival Rates in the World
Insider Monkey via Yahoo Finance· 5 days agoIn this article, we will be taking a look at the 20 countries with the highest cancer survival rates...
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric...
WTNH-TV New Haven· 1 day agoNovartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera®...
Olivia Munn Shares How Double Mastectomy Journey Impacted Son Malcolm
E! News via Yahoo News· 6 days agoOlivia Munn, who shares 2-year-old son Malcolm with partner John Mulaney, reflected on her breast ...
You may have inherited risks for developing cancer: Here's what you need to know
CBS News· 4 days agoRegular screenings are critical to identifying and treating cancer early. It's also important to be...
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation...
Digital Journal· 13 hours agoThere is an urgent need for novel, well-tolerated therapeutic options capable of changing the natural course of myelofibrosis to provide patients with deep and durable...the ...